160 related articles for article (PubMed ID: 24955652)
1. Targeting prostate carcinoma by G3-C12 peptide conjugated N-(2-hydroxypropyl)methacrylamide copolymers.
Yang Y; Li L; Zhou Z; Yang Q; Liu C; Huang Y
Mol Pharm; 2014 Oct; 11(10):3251-60. PubMed ID: 24955652
[TBL] [Abstract][Full Text] [Related]
2. Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.
Yang Y; Zhou Z; He S; Fan T; Jin Y; Zhu X; Chen C; Zhang ZR; Huang Y
Biomaterials; 2012 Mar; 33(7):2260-71. PubMed ID: 22189143
[TBL] [Abstract][Full Text] [Related]
3. G3-C12 Peptide Reverses Galectin-3 from Foe to Friend for Active Targeting Cancer Treatment.
Sun W; Li L; Yang Q; Shan W; Zhang Z; Huang Y
Mol Pharm; 2015 Nov; 12(11):4124-36. PubMed ID: 26393405
[TBL] [Abstract][Full Text] [Related]
4. Two birds, one stone: dual targeting of the cancer cell surface and subcellular mitochondria by the galectin-3-binding peptide G3-C12.
Sun W; Li L; Li LJ; Yang QQ; Zhang ZR; Huang Y
Acta Pharmacol Sin; 2017 Jun; 38(6):806-822. PubMed ID: 28065935
[TBL] [Abstract][Full Text] [Related]
5. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
[TBL] [Abstract][Full Text] [Related]
6. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
Line BR; Mitra A; Nan A; Ghandehari H
J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable brush-type copolymer modified with targeting peptide as a nanoscopic platform for targeting drug delivery to treat castration-resistant prostate cancer.
Liu T; Huang Q
Int J Pharm; 2016 Sep; 511(2):1002-11. PubMed ID: 27521701
[TBL] [Abstract][Full Text] [Related]
8. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.
Zhou Z; Li L; Yang Y; Xu X; Huang Y
Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427
[TBL] [Abstract][Full Text] [Related]
9. 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.
Kumar SR; Deutscher SL
J Nucl Med; 2008 May; 49(5):796-803. PubMed ID: 18413389
[TBL] [Abstract][Full Text] [Related]
10. A novel α
Wang F; Li L; Sun W; Li L; Liu Y; Huang Y; Zhou Z
J Drug Target; 2018 Mar; 26(3):231-241. PubMed ID: 28792244
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of primary and metastatic tumors in mice by E-selectin-targeted polymer-drug conjugates.
Shamay Y; Raviv L; Golan M; Voronov E; Apte RN; David A
J Control Release; 2015 Nov; 217():102-12. PubMed ID: 26297207
[TBL] [Abstract][Full Text] [Related]
12. Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors.
Kissel M; Peschke P; Subr V; Ulbrich K; Schuhmacher J; Debus J; Friedrich E
PDA J Pharm Sci Technol; 2001; 55(3):191-201. PubMed ID: 11417110
[TBL] [Abstract][Full Text] [Related]
13. Improvement of anti-tumor abilities on human non-small cell lung carcinoma by micellization and cross-linking of N-(2-hydroxypropyl) methacrylamide copolymers.
Zhou Z; Xu X; Li L; Huang Y
J Drug Target; 2015; 23(9):821-31. PubMed ID: 25830626
[TBL] [Abstract][Full Text] [Related]
14. Tumor targeting HPMA-porphyrin-99mTc copolymer molecular imaging agent.
Yuan L; Ma Y; Yuan J
J Biomater Sci Polym Ed; 2014; 25(18):2066-79. PubMed ID: 25315509
[TBL] [Abstract][Full Text] [Related]
15. HPMA copolymer-cyclic RGD conjugates for tumor targeting.
Pike DB; Ghandehari H
Adv Drug Deliv Rev; 2010 Feb; 62(2):167-83. PubMed ID: 19951733
[TBL] [Abstract][Full Text] [Related]
16. Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage.
Nakamura H; Etrych T; Chytil P; Ohkubo M; Fang J; Ulbrich K; Maeda H
J Control Release; 2014 Jan; 174():81-7. PubMed ID: 24269967
[TBL] [Abstract][Full Text] [Related]
17. N-(2-hydroxypropyl)methacrylamide copolymers of a glutathione (GSH)-activated glyoxalase i inhibitor and DNA alkylating agent: synthesis, reaction kinetics with GSH, and in vitro antitumor activities.
Zheng ZB; Zhu G; Tak H; Joseph E; Eiseman JL; Creighton DJ
Bioconjug Chem; 2005; 16(3):598-607. PubMed ID: 15898727
[TBL] [Abstract][Full Text] [Related]
18. Enhanced intracellular and intranuclear drug delivery mediated by biomimetic peptide SVS-1 for anticancer therapy.
Xiang Y; Chen L; Zhou R; Huang Y
Int J Pharm; 2019 Oct; 570():118668. PubMed ID: 31494237
[TBL] [Abstract][Full Text] [Related]
19. Passive and active hepatoma tumor targeting of new N-(2-hydroxypropyl)methacrylamide copolymer conjugates: synthesis, characterization, and evaluation in vitro and in vivo.
Yuan J; Yuan B; Guo H; Zeng X; Wang X; Liao S; Li J; Jia Z; Song F; Wang F
J Biomater Sci Polym Ed; 2013; 24(12):1472-83. PubMed ID: 23829459
[TBL] [Abstract][Full Text] [Related]
20. Enhanced nuclear delivery of H1-S6A, F8A peptide by NrTP6-modified polymeric platform.
Xie D; Wang F; Xiang Y; Huang Y
Int J Pharm; 2020 Apr; 580():119224. PubMed ID: 32173501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]